Advertisement for orthosearch.org.uk
Results 1 - 2 of 2
Results per page:
Applied filters
Content I can access

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 93-B, Issue SUPP_II | Pages 144 - 144
1 May 2011
Cordero-Ampuero J De Dios-Pérez M Martín-García R Martínez-Vélez D Noreña-González I De Los Santos-Real R
Full Access

Introduction: Deep infection continues to be the second most important early complication in hip arthroplasty. It is usual to apply standard prophylaxis to all patients, but it is not usual to use special measures in those of them who present a higher risk. Moreover, sometimes these patients are even not identified.

Purpose: To analyse statistically significant risk factors for deep infection in patients with a hip arthroplasty

Patients and Methods:

Design: Case-control study.

Observational and retrospective comparison of incidence or prevalence of all risk factors described in the literature. These factors have been classified according to the period of risk in: epidemiologic; pre, intra and postoperative; and distant infections.

Case series: 47 consecutive patients with a deeply infected hip arthroplasty operated in the same Department of a University General Hospital.

Control series: 200 randomly selected patients, operated in the same hospital and period of time, with no deep infection in their hip arthroplasty along follow-up.

Pearson was used for comparison of qualitative variables and ANOVA for quantitative ones.

Results: The following risk factors were significantly more frequent (p< 0.05) in the patients with an infected hip arthroplasty:

Epidemiologic characteristics: female gender, post-traumatic osteoarthritis (17% vs 3%). On the contrary, primary osteoarthritis is a “protective” factor.

Preoperative conditions: previous surgery in the same hip (60% vs 6%), obesity (BMI> 30) (9% vs 1%), chronic therapy with glucocorticoids (13% vs 0%), immunosuppressive treatments, chronic liver diseases (20% vs 2%), alcohol addiction (13% vs 0%) and intravenous drug abuse. Patients in this case-control did not present a significant difference in the prevalence of diabetes (a recognised risk factor for spine and knee surgery) or rheumatoid arthritis.

Intraoperative facts: a prolonged surgical time is the only significant risk factor (133 min vs 98 min), but differences were not found in the amount of bleeding, need for transfusion or intraoperative fractures.

Postoperative events: secretion of the wound longer than 10 days (46% vs 8%), palpable deep haematoma (27% vs 1%), dislocation of the prosthesis (40% vs 6%), and need for new surgery in the hip (21% vs 1%).

Distant infections (risk for haematogenous seeding): deep cutaneous (30% vs 8%), upper and lower urinary tract (36% vs 2%), pneumonias and bronchopneumonias (23% vs 5%), and diverse abdominal focus (14% vs 3%). On the contrary, significant differences were not found in the prevalence of severe oral or dental infections.

Conclusion: To identify significative risk factors for deep infection in hip arthroplasty is important:

to control and minimize these risk factors when present

when this is not possible not possible, to implement additional prophylactic measures.


Orthopaedic Proceedings
Vol. 92-B, Issue SUPP_IV | Pages 605 - 605
1 Oct 2010
Cordero-Ampuero J Esteban J Garcia-Cimbrelo E Hernandez A Noreña I
Full Access

Introduction: Papers about high-virulence infections are not usual, results contradictory, and orthopaedic outcomes not described.

Purpose: to compare infectious and orthopaedic results after late arthroplasty infections by single vs. polymicrobial isolates, low vs. high-virulence, and Gram-positive vs. Gram-negative organisms, when treated by exchange surgery plus long cycles of combined oral antibiotics.

Patients and Methods: A late arthroplasty infection was diagnosed in 68 consecutive patients (48 female) of 72.2(+/−10.2) years (37 hips/31 knees).

Cultures were polymicrobial in 22 cases and by Gram-positive in 55 (80.9%). Highly-resistant organisms: methicillin-resistant Staphylococcus (36 patients) and ESBL-producing Enterobacteriaceae (2 patients). “Problematic-treatment”: Enterococcus (6 patients), Pseudomonas (3 patients), non-fermenting Gram-negative (2), moulds (1).

Oral antibiotic selection: according to bacterial sensitivity, biofilm and intracellular effectiveness. Protocolized surgery: two-stage exchange. Average follow-up: 4.7+/−2.7 years (1–11).

Healing of infection is diagnosed if absence of clinical, serological and radiological signs of infection during the whole follow-up. Orthopaedic outcome is evaluated by HHS for hips and by KSCRS for knees.

Results: Surgery was not possible in 7 infections (rejected by patients), and reimplantation in 17 additional cases (patients died shortly after first surgery, rejected 2nd surgery, or was contraindicated because of medical reasons).

Healing of infection: 59/68 patients (86.8%), 32/37 hips (86.5%) and 27/31 knees (87.1%). Infection not healed: 7/68 cases (10.3%) (4/37 hips, 3/31 knees) (5 by highly-resistant and 1 by “problematic-treatment” bacteria). There are no differences between hips and knees (p=0.55).

Orthopaedic Results: HHS averages 80.5+/−16.2 (81+/−16 in healed infection, 56+/−23.5 in persistent infection). KSCRS averages 77.2/58.1 +/− 19.8/24.5 in healed infections, 32.6/0+/−25.8/0 in persistent infections. Infective and orthopaedic results present a strong statistical correlation in hips (p=0.016) and knees (p=0.0001).

Statistically significant differences are not found when comparing subgroups according to Gram stain (p=0.43), multiple vs single bacteria (p=0.47 infective, p=0.71 orthopaedic), highly-resistant bacteria (p=0.2 infective, p=0.1/0.5 orthopaedic), or “problematic-treatment” (p=0.68).

Conclusions:

A strong statistical correlation appears between infective and orthopedic results after late arthroplasty infections.

With the number of cases presented significant differences in infective or in orthopaedic results are not found when comparing single vs. polymicrobial, gram-negative vs. gram-positive, high vs. low antimicrobial resistance and “problematic-treatment” infections.